This dual action means it can: Control appetite even better than single-hormone medications Improve blood sugar control more effectively Lead to greater weight loss in many people Help your body use insulin more efficiently Tirzepatide is sold under the brand names Mounjaro for diabetes and Zepbound for weight loss
By activating GLP-1 receptors throughout your body, semaglutide: Increases Insulin Release: When blood sugar rises after meals, semaglutide signals the pancreas to release more insulin, helping move glucose from blood into cells
MeAgain, can help you navigate the transition into GLP-1 medication therapy
US obesity treatment guidelines recommend continuing anti-obesity medications if patients achieve 5% weight loss after approximately 3 months at the maintenance dose
Personal accounts from patients who have used Semaglutide, Wellbutrin, or both in tandem provide a nuanced understanding of their benefits, challenges, and the overall journey towards improved health outcomes